Vir Biotechnology, Inc. (VIR) Shareholders’ equity 2017–2025
Vir Biotechnology, Inc. (VIR) shareholders’ equity at each fiscal year-end, per SEC filings.
$765.3MFY2025 · since FY2017: -$68.9M → $765.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $765.3M | -33.5% |
| FY2024 | $1.2B | -27.7% |
| FY2023 | $1.6B | -23.5% |
| FY2022 | $2.1B | +45.1% |
| FY2021 | $1.4B | +99.7% |
| FY2020 | $716.9M | +69.1% |
| FY2019 | $423.9M | +336.6% |
| FY2018 | -$179.2M | -160.0% |
| FY2017 | -$68.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice